1. Home
  2. ARGX vs CSGP Comparison

ARGX vs CSGP Comparison

Compare ARGX & CSGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARGX
  • CSGP
  • Stock Information
  • Founded
  • ARGX 2008
  • CSGP 1987
  • Country
  • ARGX Netherlands
  • CSGP United States
  • Employees
  • ARGX N/A
  • CSGP N/A
  • Industry
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • CSGP Business Services
  • Sector
  • ARGX Health Care
  • CSGP Consumer Discretionary
  • Exchange
  • ARGX Nasdaq
  • CSGP Nasdaq
  • Market Cap
  • ARGX 40.4B
  • CSGP 33.4B
  • IPO Year
  • ARGX 2017
  • CSGP 1998
  • Fundamental
  • Price
  • ARGX $596.20
  • CSGP $79.70
  • Analyst Decision
  • ARGX Strong Buy
  • CSGP Buy
  • Analyst Count
  • ARGX 20
  • CSGP 14
  • Target Price
  • ARGX $699.56
  • CSGP $87.36
  • AVG Volume (30 Days)
  • ARGX 465.0K
  • CSGP 3.3M
  • Earning Date
  • ARGX 05-08-2025
  • CSGP 04-29-2025
  • Dividend Yield
  • ARGX N/A
  • CSGP N/A
  • EPS Growth
  • ARGX N/A
  • CSGP N/A
  • EPS
  • ARGX 12.78
  • CSGP 0.34
  • Revenue
  • ARGX $2,248,205,000.00
  • CSGP $2,736,200,000.00
  • Revenue This Year
  • ARGX $57.86
  • CSGP $15.96
  • Revenue Next Year
  • ARGX $31.90
  • CSGP $12.07
  • P/E Ratio
  • ARGX $43.64
  • CSGP $234.41
  • Revenue Growth
  • ARGX 77.22
  • CSGP 11.45
  • 52 Week Low
  • ARGX $352.77
  • CSGP $68.26
  • 52 Week High
  • ARGX $678.21
  • CSGP $93.94
  • Technical
  • Relative Strength Index (RSI)
  • ARGX 51.80
  • CSGP 53.86
  • Support Level
  • ARGX $583.00
  • CSGP $78.09
  • Resistance Level
  • ARGX $610.06
  • CSGP $81.07
  • Average True Range (ATR)
  • ARGX 24.42
  • CSGP 3.37
  • MACD
  • ARGX 4.74
  • CSGP 0.24
  • Stochastic Oscillator
  • ARGX 84.66
  • CSGP 86.11

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

About CSGP CoStar Group Inc.

CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.

Share on Social Networks: